Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry.

Authors :: De Luca L
Bolognese L
Rubboli A
Vetrano A
Callerame M
Rivetti L
Gonzini L
Gabrielli D
Di Lenarda A
Gulizia MM
Source :: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2021 May 23; Vol. 7 (3), pp. e45-e47.
Publication Year :: 2021

Subjects :: Fibrinolytic Agents adverse effects
Humans
Registries
Acute Coronary Syndrome diagnosis
Acute Coronary Syndrome drug therapy
Atrial Fibrillation diagnosis
Atrial Fibrillation drug therapy
Atrial Fibrillation epidemiology
Percutaneous Coronary Intervention adverse effects

Full Text Access

Tools